You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
重藥控股(000950.SZ)子公司應收賬款一期資產支持專項計劃掛牌轉讓申請經深交所審核無異議
格隆匯 08-16 22:12

格隆匯8月16日丨重藥控股(000950.SZ)公佈,公司第七屆董事會第二十三次會議2019年第三次臨時股東大會會議,審議通過了《關於控股子公司發行應收賬款資產支持證券票據及開展應收賬款無追索權保理業務的議案》將控股子公司重慶醫藥(集團)股份有限公司(重慶醫藥)及重慶醫藥下屬分子公司持有的應收賬款作為基礎資產發行應收賬款資產支持證券據以及開展應收賬款無追索權保理業務,其中擬發行應收賬款資產支持證券的規模不超過人民幣10億元.。

2019年8月16日,公司收到招商財富資產管理有限公司(“招商財富”)轉發的深圳證券交易所(“深交所”)《關於招商財富“招商財富-重慶醫藥應收賬款一期資產支持專項計劃”符合深交所掛牌條件的無異議函》(深證函〔2019〕436號)。

深交所對招商財富“招商財富-重慶醫藥應收賬款一期資產支持專項計劃”(以下簡稱專項計劃)《招商財富-重慶醫藥應收賬款一期資產支持專項計劃説明書》《招商財富-重慶醫藥應收賬款一期資產支持專項計劃資產買賣協議》等法律文件符合深交所掛牌要求無異議。

專項計劃發行總額不超過10億元。招商財富應當自本無異議函出具之日起12個月內正式向深交所提交掛牌申請文件,逾期未提交的,本無異議函自動失效。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account